Search PDMR transactions

Notifier
Name of person with notification obligation
Boesen Biotech ApS
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Thomas Boesen
Position
Other member of the company's administrative, management or supervisory body
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
SynAct Pharma AB
Issuer´s LEI code
549300RRYIEFEQ72N546
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share SynAct Pharma AB SE0008241491 Acquisition 2,700 Quantity 17.90 SEK 03/03/2026 NASDAQ STOCKHOLM AB
Share SynAct Pharma AB SE0008241491 Acquisition 2,750 Quantity 17.92 SEK 03/03/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
SynAct Pharma AB SE0008241491 Acquisition 03/03/2026 NASDAQ STOCKHOLM AB 5,450 (Quantity) 17.91009174 SEK
Total: 5,450
<< Back